Inspire Medical Systems, Inc. - Common Stock, $0.001 par value per share (INSP)

CUSIP: 457730109

Q4 2024 13F Holders as of 31 Dec 2024

Holder snapshot 7 signals
Share change
+35,279
Put/Call ratio
157%
SEC-reported price per share
$185.38
Indexed holders
352
Value change
-$10,392,454
Number of buys
160
Open additional details 1 more signal available
Number of sells
170
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
29,073,952

Security key

457730109

Report period

Q4 2024

Indexed institutions

352

Top holders

10

Ownership snapshot

Top reported holders of INSP - Inspire Medical Systems, Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
BlackRock, Inc.
Disclosed value leader
BlackRock, Inc.
Comparable rows
0/15
Latest evidence
30 Sep 2024
13F Highest disclosed value: $869,135,346 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

BlackRock, Inc. has the largest disclosed position value at $869.14M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BlackRock, Inc.'s linked filing trail.
Disclosed position value Top 5
BlackRock, Inc. $869.14M
VANGUARD GROUP INC $682.14M
WELLINGTON MANAGEMENT GROUP LLP $293.85M
BAILLIE GIFFORD & CO $288.47M
WASATCH ADVISORS LP $279.32M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
BlackRock, Inc.
13F
Company
13F
—
denominator unverified
$869,135,346
4,118,149 shares
— 30 Sep 2024
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$682,142,725
3,232,138 shares
— 30 Sep 2024
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
13F
—
denominator unverified
$293,852,091
1,392,334 shares
— 30 Sep 2024
BAILLIE GIFFORD & CO
13F
Company
13F
—
denominator unverified
$288,470,525
1,366,835 shares
— 30 Sep 2024
WASATCH ADVISORS LP
13F
Company
13F
—
denominator unverified
$279,318,344
1,323,470 shares
— 30 Sep 2024
STATE STREET CORP
13F
Company
13F
—
denominator unverified
$221,556,913
1,049,784 shares
— 30 Sep 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Indexed institutions
352
Shares
33,398,911
Indexed holders
352
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Reported share positions only; options and principal amounts are excluded. Missing manager disclosures are unavailable, not zero. A missing position becomes zero only when complete coverage is verified for both snapshots. Counts describe the indexed universe; the comparison may cover a smaller set.

Compare Q4 2024 vs Q3 2024 Across Filers

Q3 2024 indexed holders
343
Q4 2024 indexed holders
352
Indexed holder difference
9
Investor Q3 2024 Shares Q4 2024 Shares Share Diff Share Chg % Q3 2024 value Q4 2024 value Value change Value Chg %

Trend: the last eight indexed quarters, including the selected comparison periods.

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .